Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002052587-25-000003
Filing Date
2025-01-28
Accepted
2025-01-28 15:36:56
Documents
2
Period of Report
2017-02-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6675
2 DURABLE POWER OF ATTORNEY boniukmiltonpoa4.txt EX-24 7967
  Complete submission text file 0002052587-25-000003.txt   16064
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Issuer) CIK: 0001379006 (see all company filings)

EIN.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NANOVIRICIDES, INC. 135 WOOD STREET, SUITE 205 WEST HAVEN CT 06516
Business Address
BONIUK MILTON (Reporting) CIK: 0001580568 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36081 | Film No.: 25563876